PANATecs GmbH Appoints Rainer Baule, Chairman of the Board of Fresenius Kabi AG, to the Advisory Board
Prof. Peter Ruppersberg is leaving the Advisory Board of PANATecs GmbH on 27 April 2010 at his own wish. His successor is Rainer Baule, Member of the Board of Fresenius SE and Chairman of the Board of Fresenius Kabi AG.
Prof. Peter Ruppersberg has resigned his position as Member of the Advisory Board of the firm of PANATecs, as his business activities have shifted to Switzerland. He has been active in the Advisory Board of PANATecs GmbH since the founding and has made an essential contribution to the development of the company.
In the name of all partners, Dr. Benedikt Merz, Managing Director of PANATecs GmbH, thanked Prof. Peter Ruppersberg for his many years of trendsetting work in the Advisory Board, particularly when the company was starting and expanding.
Rainer Baule has been a member of the Board of Fresenius SE since 1 June 1997. He has been Chairman of the Board of Fresenius Kabi AG since 7 May 2001. From 1996 to 1997, he was Chairman of the Board of Management of EG&G Berthold, Bad Wildbad. Since 1979, he has had various managerial positions in the Carl Zeiss Group in Oberkochen - both in Germany and in the USA. He was most recently company divisional director and member of Zeiss group management. His first position was as managing partner in Komeg-Kontroll-Technik GmbH, Riegelsberg. Rainer Baule studied industrial engineering at Darmstadt Technical University.
Rainer Baule's work in the PANATecs GmbH Advisory Board will be in collaboration with the Chairman, Günter Steffen, ZFHN Zukunftsfonds Beteiligungs-Gmbh & Co. KG, and the Deputy Chairman, Prof. Gerhard Anton Müller MD, Faculty of Medicine, Göttingen University.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

A self-cleaning surface that repels even the deadliest superbugs

Maple syrup protects neurons and nurtures young minds - How maple syrup prevents the development of amyotrophic lateral sclerosis in the C. elegans worm

HIV infection: the brevity of the right moment
EuropaBio Responds to the Eurobarometer on Biotechnology 2010

The 'blue' in blueberries can help lower blood pressure
Laser treatment may boost effectiveness of brain tumor drugs
Deuteromycota
Proteomics can improve breast cancer treatment

A new molecule to target and eliminate cancer cells using light - This new photosensitizer has proved much more effective than those used in current treatments.
Evotec and MaRS Innovation announce first funded project under LAB150 BRIDGE
